Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis

The effectiveness of neoadjuvant therapy (NAT) remains unclear in resectable pancreatic cancer (PC) as compared with upfront surgery (US). The aim of this study was to investigate the survival gain of NAT over US in resectable PC. PubMed and EMBASE were searched for studies comparing survival outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoon Suk, Lee, Jong-Chan, Yang, Se Yeol, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821820/
https://www.ncbi.nlm.nih.gov/pubmed/31666626
http://dx.doi.org/10.1038/s41598-019-52167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821820/
https://www.ncbi.nlm.nih.gov/pubmed/31666626
http://dx.doi.org/10.1038/s41598-019-52167-9

Ejemplares similares